Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Genome-based Drug Discovery

PUBLISHER: Grand View Research | PRODUCT CODE: 1553598

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1553598

Structural Biology & Molecular Modeling Techniques Market Size, Share & Trends Analysis Report By Tools (SaaS & Standalone Modeling), By Application (Drug Development), By Region, And Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

Structural Biology & Molecular Modeling Techniques Market Growth & Trends:

The global structural biology & molecular modeling techniques market size is expected to reach USD 19.17 billion by 2030, registering to grow at a CAGR of 15.4% from 2024 to 2030 according to a new report by Grand View Research, Inc. An unprecedented rise in the adoption of unhealthy lifestyles has led to an upsurge in the prevalence of chronic diseases, such as diabetes and cancer, which is presumed to propel the market growth during the forecast period.

Moreover, increasing drug resistance coupled with the high drug attrition rate is engendering the requirement for extensive R&D activities, which is presumed to boost the adoption of structural biology & molecular modeling techniques in the drug discovery and development process. This is expected to serve as an efficient approach in fast tracking the development of drugs with high potency.

The heightening demand for molecular modeling techniques is predominantly attributable to the significant cost reduction enabled. This is due to the fact that prediction software identifies possible adverse reactions and determines drug efficacy and toxicity in the pre-clinical stages, thereby reducing the probability of drug failure at the later stages. Consequentially, the aforementioned factors serve as prominent reasons responsible for the widened market demand.

Structural Biology & Molecular Modeling Techniques Market Report Highlights:

  • SaaS & standalone modeling held the largest share of the tools segment in 2023 owing to extensive utilization of computer-assisted structuring and modeling techniques in R&D
  • The drug discovery segment is anticipated to grow at a lucrative CAGR owing to continual introduction of software modifications with focus on enhanced drug designing aimed to accelerate the process in identifying novel therapeutic agents
  • In 2023, North America dominated the global structural biology & molecular modeling techniques market owing to the presence of a wide number of established pharmaceutical companies extensively involved in the commercialization of in silico tools to promote their usage
  • Asia Pacific is expected to grow at an exponential CAGR owing to favorable government initiatives supporting research activities and the increasing trend of outsourcing drug development by the developed economies
  • The key participants are employing clinical and research collaborative strategies promoting the adoption of structural prediction software and databases to gain a competitive advantage
Show more
Product Code: GVR-1-68038-737-7

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Structural Biology & Molecular Modeling Techniques Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Structural Biology & Molecular Modeling Techniques Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Structural Biology & Molecular Modeling Techniques Market: Tools Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Structural Biology & Molecular Modeling Techniques Market: Tools Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. SaaS & standalone modeling
    • 4.3.1. SaaS & Standalone Modeling Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Homology Modeling
      • 4.3.2.1. Homology Modeling Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Threading
      • 4.3.3.1. Threading Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Molecular Dynamics
      • 4.3.4.1. Molecular Dynamics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Ab Initio
      • 4.3.5.1. Ab Initio Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Hybrid
      • 4.3.6.1. Hybrid Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.7. Others
      • 4.3.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Visualization & analysis
    • 4.4.1. Visualization & analysis Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Databases
    • 4.5.1. Databases Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Structural Biology & Molecular Modeling Techniques Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Structural Biology & Molecular Modeling Techniques Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Drug Development
    • 5.3.1. Drug Development Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Drug Discovery
    • 5.4.1. Drug Discovery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Others
    • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Structural Biology & Molecular Modeling Techniques Market: Regional Estimates & Trend Analysis

  • 6.1. Structural Biology & Molecular Modeling Techniques Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Australia
      • 6.4.6.1. Australia Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. South Africa
      • 6.6.4.1. South Africa Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Structural Biology & Molecular Modeling Techniques Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Acellera Therapeutics Inc
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Agilent Technologies, Inc
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Labvantage - Biomax GmbH
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Bruker
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Chemical Computing Group ULC
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Dassault Systemes
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Illumina, Inc.
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Thermo Fisher Scientific Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. CD BioSciences
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Charles River Systems, Inc.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!